Lumexa Imaging Holdings Inc. Common Stock (LMRI)
Stock · NASDAQ · Health Care
$10.8as of 10/16/2026
Price chart
Active signals
Resistance level
$11.74
Industry
Medical Specialities
About LMRI
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is ba…
- Sector
- Health Care
- Industry
- Medical Specialities
- Employees
- 5,000
- Website
- www.lumexaimaging.com/
Fundamentals
- 1-day range
- $10.6$10.99
- Market cap
- $1.10B
- P/E (trailing)
- —
- P/E (forward)
- 12.11
- EPS (trailing)
- $-0.43
- Dividend yield
- —
- Beta
- 1.11
- Avg. volume
- 414.3K
52-week range
$6.45$19.45
Next earnings: November 12, 2026 · EPS estimate $0.18
Forecasts
9 analyst ratings
Buy 93%
Hold 7%
Sell 0%
1-year price forecast
High
$23
+113.0%
Median
$18
+66.7%
Low
$13
+20.4%
Lumexa Imaging Holdings Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- LMRILumexa Imaging Holdings Inc. Common Stock$10.78▲ 0.00%Market cap $1.10BP/E —$6.45$19.45
- FRNMFreenome Inc. Common stock$11.75▼ 4.35%Market cap $1.17BP/E —$9.97$17.5
- TRUPTrupanion Inc. Common Stock$28.12▲ 0.93%Market cap $1.23BP/E 53.48$21.16$46.98
- CSTLCastle Biosciences Inc. Common Stock$31.96▼ 5.44%Market cap $930.84MP/E —$17.72$44.28
- PSNLPersonalis Inc. Common Stock$15.65▼ 1.76%Market cap $1.39BP/E —$4.96$18.89
- FTREFortrea Holdings Inc. Common Stock$22.49▼ 1.12%Market cap $1.68BP/E —$8.55$23.51
- FLGTFulgent Genetics Inc. Common Stock$19.81▼ 7.17%Market cap $510.41MP/E —$13.46$31.04
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| LMRI Lumexa Imaging Holdings Inc. Common Stock | $1.10B | — | $10.78 | ▲ 0.00% | $6.45$19.45 |
| FRNM Freenome Inc. Common stock | $1.17B | — | $11.75 | ▼ 4.35% | $9.97$17.5 |
| TRUP Trupanion Inc. Common Stock | $1.23B | 53.48 | $28.12 | ▲ 0.93% | $21.16$46.98 |
| CSTL Castle Biosciences Inc. Common Stock | $930.84M | — | $31.96 | ▼ 5.44% | $17.72$44.28 |
| PSNL Personalis Inc. Common Stock | $1.39B | — | $15.65 | ▼ 1.76% | $4.96$18.89 |
| FTRE Fortrea Holdings Inc. Common Stock | $1.68B | — | $22.49 | ▼ 1.12% | $8.55$23.51 |
| FLGT Fulgent Genetics Inc. Common Stock | $510.41M | — | $19.81 | ▼ 7.17% | $13.46$31.04 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- This Vertiv Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Mondaybenzinga · 10/5/2026
- This Vertiv Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For MondayBenzinga · 10/5/2026
- Truist Securities Initiates Coverage On Lumexa Imaging Hldgs with Buy Rating, Announces Price Target of $18Benzinga · 10/5/2026
- Keybanc Initiates Coverage On Lumexa Imaging Hldgs with Overweight Rating, Announces Price Target of $18Benzinga · 9/25/2026
- Lumexa Imaging Holdings (LMRI) Could Be 36% Below Fair Value On Its Imaging Growth StoryYahoo · 9/20/2026
- Lumexa (LMRI) Upgraded to Buy: Here's What You Should KnowYahoo · 9/15/2026
Insider Activity
Insider Actions →Acquired
200.5K
Disposed
0
- Matthew Lungren · June 10, 2026 · Grant19.4K
- Henry Lee Cooper · June 10, 2026 · Grant19.4K
- Bridget E. Karlin · June 10, 2026 · Grant19.4K
- Molly Joseph · June 10, 2026 · Grant19.4K
- Brett Brodnax · June 10, 2026 · Grant19.4K
- Glenn A. Eisenberg · June 10, 2026 · Grant19.4K
- Robert Louis Mittl Jr. · June 10, 2026 · Grant19.4K
- Brett Brodnax · May 19, 2026 · Buy35.0K @ $7.25
- Henry Lee Cooper · May 14, 2026 · Buy30.0K @ $7.44
Institutional Ownership
March 31, 2026
- Total shares held
- 30.52M
- Total value held
- $290.40M
- Institutional holders
- 86
Top holders this quarter
- Unknown2.98M
- Unknown2.33M
- Unknown2.10M
- Unknown1.71M
- Unknown1.65M
- Unknown1.53M
- Unknown1.44M
- Unknown1.30M
- Unknown1.06M
- Unknown923.7K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Lumexa Imaging (LMRI) Valuation Analysis Published
A recent analysis suggests Lumexa Imaging Holdings may be trading at a discount to its estimated fair value, citing the company's imaging growth story. The stock is currently trading below the average analyst target price of $17.57. This valuation perspective provides context for investors assessing the company's current market position relative to its long-term potential.
Lumexa Imaging (LMRI) Valuation Analysis Published. A recent analysis suggests Lumexa Imaging Holdings may be trading at a discount to its estimated fair value, citing the company's imaging growth story. The stock is currently trading below the average analyst target price of $17.57. This valuation perspective provides context for investors assessing the company's current market position relative to its long-term potential.